Cubist Systematic Strategies, LLC Relay Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.5 - $12.07 $9,217 - $14,834	1,229 New	1,229 $10,000
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $837,282 - $1.32 Million	101,612 Added 57.25%	279,115 $2.35 Million
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $1.77 Million - $3.24 Million	177,503 New	177,503 $2.23 Million
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $150,464 - $255,236	10,626 Added 20.46%	62,560 $934,000
Q3 2022 Nov 14, 2022	SELL	$18.07 - $31.37 $131,658 - $228,561	-7,286 Reduced 12.3%	51,934 $1.16 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $557,981 - $1.46 Million	41,922 Added 242.35%	59,220 $992,000
Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $195,569 - $312,371	9,653 Added 126.27%	17,298 $518,000
Q4 2021 Feb 14, 2022	SELL	$26.0 - $37.03 $1.53 Million - $2.17 Million	-58,673 Reduced 88.47%	7,645 $235,000
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $1.14 Million - $1.46 Million	38,385 Added 137.42%	66,318 $2.09 Million
Q2 2021 Aug 16, 2021	SELL	$27.5 - $38.19 $23,485 - $32,614	-854 Reduced 2.97%	27,933 $1.02 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $402,825 - $762,172	12,387 Added 75.53%	28,787 $995,000
Q4 2020 Feb 16, 2021	BUY	$35.51 - $54.03 $66,794 - $101,630	1,881 Added 12.96%	16,400 $682,000
Q3 2020 Nov 16, 2020	BUY	$32.81 - $45.1 $476,368 - $654,806	14,519 New	14,519 $618,000

182

126M

1.7K

18K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $780M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.